모바일 심장 텔레메트리 시스템 시장 : 제품 유형별, 적응증별, 최종 용도별 - 세계 예측

Global Mobile Cardiac Telemetry Systems Market will witness a 12.1% CAGR between 2024 and 2032, fueled by continuous product launches and advancements in the field. These systems offer real-time monitoring of cardiac activities outside of traditional clinical settings, providing early detection and intervention for cardiac conditions. Leading companies are innovating with smaller, more portable devices equipped with advanced sensors and connectivity features, enhancing patient comfort and data accuracy. For instance, in May 2024, Vivalink introduced a comprehensive technology solution tailored for Mobile Cardiac Telemetry (MCT) and Holter monitoring. This integrated solution combines remote patient monitoring (RPM) technologies with advanced algorithms for detecting arrhythmias.

The rise in cardiovascular diseases globally, coupled with an aging population, drives the market further. Mobile cardiac telemetry systems enable continuous monitoring over extended periods, improving diagnostic accuracy and patient outcomes. Additionally, the integration of artificial intelligence and machine learning into these systems enhances data interpretation and diagnostic capabilities. As healthcare providers prioritize remote patient monitoring and personalized care, the Mobile Cardiac Telemetry Systems Market is poised for significant growth with ongoing technological innovations.

The overall Mobile Cardiac Telemetry Systems Industry size is classified based on the product type, indication, end-use, and region.

The Mobile Cardiac Telemetry Systems Market is experiencing rising demand for patch-based solutions due to their convenience and effectiveness in continuous heart monitoring. These wearable patches provide real-time data on cardiac activity, offering patients and healthcare providers insights into heart health without the constraints of traditional monitoring devices. Patch-based systems are gaining popularity for their comfort, ease of use, and ability to detect arrhythmias and other cardiac abnormalities promptly. As the healthcare industry shifts towards remote patient monitoring and personalized care, the demand for patch-based mobile cardiac telemetry systems is expected to grow, supported by ongoing technological advancements and improved patient outcomes.

The Mobile Cardiac Telemetry Systems Market is seeing increased demand for coronary artery monitoring solutions, driven by the rising prevalence of coronary artery disease (CAD). These systems enable continuous monitoring of patients' heart activity, crucial for the early detection and management of CAD-related issues. Mobile cardiac telemetry provides real-time data on heart function, helping healthcare providers intervene promptly to prevent complications. With CAD being a leading cause of mortality worldwide, the need for effective monitoring solutions that can detect and monitor coronary artery conditions remotely is driving market growth and enhancing patient care and outcomes.

The Mobile Cardiac Telemetry Systems Market in Europe is experiencing robust demand driven by advancements in healthcare technology and increasing cardiovascular disease prevalence. These systems offer continuous monitoring of cardiac activity outside clinical settings, supporting early diagnosis and personalized treatment. European healthcare systems prioritize remote patient monitoring to improve outcomes and reduce hospitalizations. As aging populations and chronic disease rates rise, there's a growing need for efficient cardiac monitoring solutions. Innovations in mobile cardiac telemetry, including enhanced data analytics and connectivity, cater to these needs, positioning the European market for significant growth in the coming years.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing incidence of cardiac disorders
    • 3.2.1.2 Favorable government policies
    • 3.2.1.3 Growing aging population
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Lack of professional training & education
    • 3.2.2.2 Stringent regulatory policies and quality control standards
• 3.3 Growth potential analysis
• 3.4 Technological landscape
• 3.5 Regulatory landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive positioning matrix
• 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Lead-based
• 5.3 Patch-based

Chapter 6 Market Estimates and Forecast, By Indication, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Angina pectoris
• 6.3 Coronary artery disease
• 6.4 Atherosclerosis
• 6.5 Heart failure
• 6.6 Stroke
• 6.7 Other indications

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Specialty clinics
• 7.4 Diagnostic centers
• 7.5 Homecare settings
• 7.6 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 ACS Diagnostics
• 9.2 Baxter International Inc.
• 9.3 BIOTRICITY INC.
• 9.4 Boston Scientific Cardiac Diagnostics Inc.
• 9.5 iRhythm Technologies, Inc.
• 9.6 Koninklijke Philips N.V.
• 9.7 Medicomp Systems
• 9.8 ScottCare Cardiovascular Solutions
• 9.9 Telerhythmics LLC
• 9.10 Zoll Medical Corporation